Screening for hepatocellular carcinoma: Why, when, how?

Current Gastroenterology Reports

Volumn 5, Issue 1, 2003, Pages 57-62

  Arguedas, Miguel R ^a  

^a UNIVERSITY OF ALABAMA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN; BIOLOGICAL MARKER;

ALCOHOLISM; CANCER INCIDENCE; CANCER MORTALITY; CANCER SCREENING; CANCER SURVIVAL; COMPUTER ASSISTED TOMOGRAPHY; COST EFFECTIVENESS ANALYSIS; HEMOCHROMATOSIS; HEPATITIS B; HEPATITIS C; HUMAN; LIVER CARCINOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOGENESIS; PRIMARY BILIARY CIRRHOSIS; REVIEW; SENSITIVITY AND SPECIFICITY; ULTRASOUND; COST BENEFIT ANALYSIS; ECONOMICS; LIVER CELL CARCINOMA; LIVER TUMOR;

ALPHA-FETOPROTEINS; BIOLOGICAL MARKERS; CARCINOMA, HEPATOCELLULAR; COST-BENEFIT ANALYSIS; HUMANS; LIVER NEOPLASMS; MAGNETIC RESONANCE IMAGING; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0037607649     PISSN: 15228037     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11894-003-0010-1     Document Type: Review

References (42)

1. Bosch FX, Ribes J, Borras J: Epidemiology of primary liver cancer. Semin Liver Dis 1999, 19:271-285.
2. Macdonald GA: Pathogenesis of hepatocellular carcinoma. Clin Liver Dis 2001, 5:69-85.
3. El-Serag H, Mason A, Key C: Trends in survival of patients with hepatocellular carcinoma between 1977 and 1996 in the United States. Hepatology 2001, 33:62-65.
4. Sackett DL, Haynes RB, Tugwell P: Clinical Epidemiology: A Basic Science for Clinical Medicine. Boston: Little, Brown; 1985.
5. Sherman M: Surveillance for hepatocellular carcinoma. Semin Oncol 2001, 28:450-459.
6. El-Serag H: Epidemiology of hepatocellular carcinoma. Clin Liver Dis 2001, 5:87-108.
7. Zen Y, Katayanagi K, Tsuneyama K, et al.: Hepatocellular carcinoma arising in non-alcoholic steatohepatitis. Pathol Int 2001, 51:127-131.
8. Di Bisceglie AM, Carithers RL Jr, Gores GJ: Hepatocellular carcinoma. Hepatology 1998, 28:1161-1165.
9. Collier J, Sherman M: Screening for hepatocellular carcinoma. Hepatology 1998, 27:273-278.
10. Kew MC: Hepatocellular cancer: a century of progress. Clin Liver Dis 2000, 4:257-268.
11. Llovet JM, Bustamante J, Castells A, et al.: Natural history of untreated non-surgical hepatocellular carcinoma: rationale for the design and evaluation of therapeutic trials. Hepatology 1999, 29:62-67.
12. Johnson PJ: The role of serum alpha-fetoprotein estimation in the diagnosis and management of hepatocellular carcinoma. Clin Liver Dis 2001, 5:145-160.
13. Shiina S, Tagawa K, Unuma T et al.: Percutaneous alcohol injection therapy for hepatocellular carcinoma: a histopathological study. Cancer 1991, 68:1524-1530.
14. McMahon BJ, Bulkow L, Harpster A, et al.: Screening for hepatocellular carcinoma in Alaska natives infected with chronic hepatitis B: a 16-year population-based study. Hepatology 2000, 32:842-846.
15. Chen CJ, Lu SN, You SL, et al.: Community-based hepatocellular carcinoma screening in seven townships in Taiwan. J Formos Med Assoc 1995, 94(Suppl 2):S94-S102.
16. Lok AS, Lai CL: Alpha-fetoprotein monitoring in Chinese patients with chronic hepatitis B virus infection: role in the early detection of hepatocellular carcinoma. Hepatology 1989, 9:110-115.
17. Cottone M, Turri M, Caltagirone M, et al.: Screening for hepatocellular carcinoma in patients with Child's A cirrhosis: an 8-year prospective study by ultrasound and alpha-fetoprotein. J Hepatol 1994, 21:1029-1034.
18. Colombo M: Screening for cancer in viral hepatitis. Clin Liver Dis 2001, 5:109-122.
19. Tong MJ, Blatt LM, Kao VW: Surveillance for hepatocellular carcinoma in patients with chronic viral hepatitis in the United States of America. J Gastroenterol Hepatol 2001, 16:553-559.
20. Chalasani N, Horlander SC Sr, Said A, et al.: Screening for hepatocellular carcinoma in advanced cirrhosis. Am J Gastroenterol 1999, 94:2988-2993.
21. Okano H, Shiraki K, Inoue H, et al.: Comparison of screening methods for hepatocellular carcinomas in patients with cirrhosis. Anticancer Res 2001, 21:2979-2982.
22. Palma LD: Diagnostic imaging and interventional therapy for hepatocellular carcinoma. Br J Radiol 1998, 71:808-818.
23. Bolondi L, Sofia S, Siringo S, et al.: Surveillance programme of cirrhotic patients for early diagnosis and treatment of hepatocellular carcinoma: a cost effectiveness analysis. Gut 2001, 48:251-259.
24. Charnsangavej C: Computed tomography. In Imaging in Hepatobiliary and Pancreatic Disease: A Practical Clinical Approach. Edited by Van Leeuwen DJ, Reeders JWAJ, Ariyama J. London: WB Saunders; 2000:267-281.
25. Peterson MS, Baron RL: Radiographic diagnosis of hepatocellular carcinoma. Clin Liver Dis 2001, 5:123-144.
26. Mortele KJ, De Keukeleire K, Praet M, et al.: Malignant focal hepatic lesions complicating underlying liver disease: dualphase contrast-enhanced spiral CT sensitivity and specificity in orthotopic liver transplant patients. Eur Radiol 2001, 11:1631-1638.
27. Rode A, Bancel B, Douek P, et al.: Small nodule detection in cirrhotic livers: evaluation with US, spiral CT, and MRI and correlation with pathologic examination of explanted liver. J Comput Assist Tomogr 2001, 25:327-336.
28. Lim JH, Kim CK, Lee WJ, et al.: Detection of hepatocellular carcinomas and dysplastic nodules in cirrhotic livers: accuracy of helical CT in transplant patients. AJR Am J Roentgenol 2000, 175:693-698.
29. Lopez Hanninen E, Vogl TJ, Bechstein WO, et al.: Biphasic computed tomography for detection of hepatocellular carcinoma before resection or orthotopic liver transplantation. Invest Radiol 1998, 33:216-221.
30. Peterson MS, Baron RL, Marsh JW Jr, et al.: Pretransplantation surveillance for possible hepatocellular carcinoma in patients with cirrhosis: epidemiology and CT-based tumor detection rate in 430 cases with surgical pathologic correlation. Radiology 2000, 217:743-749.
31. Winter TC 3rd, Takayasu K, Muramatsu Y, et al.: Early advanced hepatocellular carcinoma: evaluation of CT and MR appearance with pathologic correlation. Radiology 1994, 192:379-387.
32. Murakami T, Mochizuki K, Nakamura H: Imaging evaluation of the cirrhotic liver. Semin Liver Dis 2001, 21:213-224.
33. Krinsky GA, Lee VS, Theise ND, et al.: Hepatocellular carcinoma and dysplastic nodules in patients with cirrhosis: prospective diagnosis with MR imaging and explantation correlation. Radiology 2001, 219:445-454.
34. Sheu JC, Sung JL, Chen DS, et al.: Growth rate of asymptomatic hepatocellular carcinoma and its clinical implications. Gastroenterology 1985, 89:259-266.
35. Henrion J, Libon E, De Maeght S, et al.: Surveillance for hepatocellular carcinoma: compliance and results according to the aetiology of cirrhosis in a cohort of 141 patients. Acta Gastroenterol Belg 2000, 63:5-9.
36. Yuen MF, Cheng CC, Lauder IJ, et al.: Early detection of hepatocellular carcinoma increases the chance of treatment: Hong Kong experience. Hepatology 2000, 31:330-335.
37. Sarasin FP, Giostra E, Hadengue A: Cost-effectiveness of screening for detection of small hepatocellular carcinoma in Western patients with Child-Pugh class A cirrhosis. Am J Med 1996, 101:422-434.
38. Everson GT: Increasing incidence and pretransplantation screening of hepatocellular carcinoma. Liver Transpl 2000, 6 (Suppl):S2-S10.
39. Fattovich G, Giustina G, Degos F, et al.: Effectiveness of interferon alfa on incidence of hepatocellular carcinoma and decompensation in cirrhosis type C. European Concerted Action on Viral Hepatitis (EUROHEP). J Hepatol 1997, 27:201-205.
40. Miyakawa H, Sato C, Tazawa J, et al.: A prospective study on hepatocellular carcinoma in liver cirrhosis: respective roles of alcohol and hepatitis C virus infection. Alcohol Alcohol Suppl 1994, 29:75-79.
41. Fracanzani AL, Borzio M, Roncalli M, et al.: Can large cell change and high proliferative activity predict hepatocellular carcinoma in patients with hereditary hemochromatosis? Am J Gastroenterol 2000, 95:2940-2945.
42. Caballeria L, Pares A, Castells A, et al.: Hepatocellular carcinoma in primary biliary cirrhosis: similar incidence to that in hepatitis C virus-related cirrhosis. Am J Gastroenterol 2001, 96:1160-1163.